United Capital Financial Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.12M Buy
7,936
+110
+1% +$29.8K 0.01% 534
2025
Q4
$1.96M Sell
7,826
-1,048
-12% -$278K 0.01% 540
2025
Q3
$2.55M Buy
8,874
+1,662
+23% +$445K 0.02% 418
2025
Q2
$1.89M Sell
7,212
-261
-3% -$63.6K 0.02% 455
2025
Q1
$1.74M Buy
7,473
+81
+1% +$19.7K 0.01% 453
2024
Q4
$1.7M Sell
7,392
-159
-2% -$36.5K 0.01% 453
2024
Q3
$1.69M Buy
7,551
+507
+7% +$111K 0.01% 451
2024
Q2
$1.43M Sell
7,044
-542
-7% -$110K 0.01% 459
2024
Q1
$1.66M Sell
7,586
-308
-4% -$67.8K 0.01% 463
2023
Q4
$1.79M Sell
7,894
-11,556
-59% -$2.43M 0.01% 431
2023
Q3
$3.91M Sell
19,450
-797
-4% -$168K 0.03% 332
2023
Q2
$4.2M Sell
20,247
-2,422
-11% -$470K 0.02% 339
2023
Q1
$4.47M Buy
22,669
+1,045
+5% +$215K 0.02% 332
2022
Q4
$4.37M Sell
21,624
-1,032
-5% -$202K 0.02% 350
2022
Q3
$3.99M Sell
22,656
-205
-0.9% -$42K 0.02% 359
2022
Q2
$4.6M Sell
22,861
-204
-0.9% -$43.5K 0.03% 348
2022
Q1
$5.22M Buy
23,065
+99
+0.4% +$23.3K 0.03% 362
2021
Q4
$6.2M Sell
22,966
-4,478
-16% -$1.11M 0.03% 346
2021
Q3
$6.64M Sell
27,444
-201
-0.7% -$50.7K 0.03% 329
2021
Q2
$6.55M Sell
27,645
-279
-1% -$63.6K 0.03% 340
2021
Q1
$6.12M Sell
27,924
-2,286
-8% -$459K 0.03% 333
2020
Q4
$5.28M Buy
30,210
+685
+2% +$118K 0.03% 345
2020
Q3
$4.78M Sell
29,525
-739
-2% -$117K 0.03% 351
2020
Q2
$4.32M Sell
30,264
-1,949
-6% -$270K 0.03% 386
2020
Q1
$3.5M Sell
32,213
-4,644
-13% -$669K 0.03% 397
2019
Q4
$5.36M Buy
36,857
+1,924
+6% +$278K 0.03% 412
2019
Q3
$5.04M Sell
34,933
-7,587
-18% -$1.11M 0.04% 413
2019
Q2
$6.32M Buy
42,520
+4,541
+12% +$634K 0.04% 376
2019
Q1
$4.99M Buy
37,979
+6,274
+20% +$773K 0.04% 413
2018
Q4
$3.44M Buy
31,705
+65
+0.2% +$8.71K 0.03% 443
2018
Q3
$4.72M Sell
31,640
-128
-0.4% -$19.5K 0.03% 444
2018
Q2
$4.9M Sell
31,768
-594
-2% -$89.7K 0.04% 418
2018
Q1
$4.5M Sell
32,362
-796
-2% -$117K 0.03% 427
2017
Q4
$4.58M Buy
33,158
+245
+0.7% +$32.4K 0.04% 424
2017
Q3
$4.27M Sell
32,913
-845
-3% -$113K 0.04% 416
2017
Q2
$4.47M Buy
33,758
+136
+0.4% +$16.7K 0.04% 402
2017
Q1
$4.14M Sell
33,622
-2,161
-6% -$256K 0.04% 399
2016
Q4
$3.95M Sell
35,783
-1,830
-5% -$203K 0.04% 415
2016
Q3
$4.44M Buy
37,613
+1,775
+5% +$209K 0.04% 404
2016
Q2
$4M Sell
35,838
-1,652
-4% -$178K 0.04% 404
2016
Q1
$3.77M Sell
37,490
-8,298
-18% -$796K 0.04% 394
2015
Q4
$4.86M Sell
45,788
-6,380
-12% -$658K 0.06% 335
2015
Q3
$4.86M Sell
52,168
-5,663
-10% -$586K 0.06% 325
2015
Q2
$6.02M Buy
57,831
+2,824
+5% +$294K 0.07% 307
2015
Q1
$5.65M Sell
55,007
-5,313
-9% -$546K 0.07% 308
2014
Q4
$5.59M Buy
60,320
+18,417
+44% +$1.63M 0.08% 242
2014
Q3
$3.66M Sell
41,903
-34,329
-45% -$3.1M 0.06% 306
2014
Q2
$6.71M Sell
76,232
-2,335
-3% -$202K 0.12% 202
2014
Q1
$6.63M Sell
78,567
-1,140
-1% -$90.9K 0.14% 174
2013
Q4
$6.26M Buy
79,707
+5,047
+7% +$430K 0.21% 123
2013
Q3
$6.36M Sell
74,660
-2,794
-4% -$235K 0.2% 111
2013
Q2
$6.66M Buy
+77,454
New +$6.43M 0.18% 145

Other funds holding LH

United Capital Financial Advisors's LH Position: Q1 2026 in Review

United Capital Financial Advisors increased its Labcorp (LH) stake by 1.4% in Q1 2026, buying an estimated $29.8K and bringing the position to 7,936 shares worth $2.12M. The position accounts for 0.01% of the portfolio, ranked #534.

United Capital Financial Advisors first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.71M in Q2 2014. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • United Capital Financial Advisors held 7,936 shares of Labcorp worth $2.12M as of Q1 2026.
  • United Capital Financial Advisors bought 110 Labcorp shares in Q1 2026, an estimated $29.8K.
  • Labcorp made up 0.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #534 holding.
  • United Capital Financial Advisors first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • United Capital Financial Advisors's Labcorp position peaked at $6.71M in Q2 2014.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.